Recognizing the significance of Charcot-Marie-Tooth disease and the need for robust funding of the National Institute of Neurological Disorders and Stroke at the National Institutes of Health.

House Resolution

H.Res. 1079

119th Congress

Recognizing the significance of Charcot-Marie-Tooth disease and the need for robust funding of the National Institute of Neurological Disorders and Stroke at the National Institutes of Health.

In Committee

Introduced:Feb 25, 2026

Primary Sponsor

Josh Gottheimer

D - NJ

Cosponsors

0

Quick Stats

Summary

This resolution calls attention to Charcot-Marie-Tooth disease (CMT), a group of inherited nerve disorders affecting approximately 1 in 2,500 Americans, and urges increased funding for neurological research at the National Institutes of Health. CMT causes progressive muscle weakness and loss of sensation, particularly in the feet, legs, hands, and arms, and currently has no cure. The resolution seeks to elevate awareness of this under-recognized disease and strengthen the federal commitment to finding treatments.

Latest Action

Referred to the House Committee on Energy and Commerce.

Introduced2/25/2026

StatusReferred to the House Committee on Energy and Commerce.

ChamberHouse

Data from Congress.gov

See this page through your district lens

Enter ZIP to personalize representatives and vote context.

Stay on top of this issue

Subscribe for weekly bill and representative updates.

Vote Prediction

Recognizing the significance of Charcot-Marie-Tooth disease and the need for robust funding of the National Institute of Neurological Disorders and Stroke at the National Institutes of Health.

This resolution calls attention to Charcot-Marie-Tooth disease (CMT), a group of inherited nerve disorders affecting approximately 1 in 2,500 Americans, and urges increased funding for neurological research at the National Institutes of Health. CMT causes prog

Community Breakdown

Pass

0%

Fail

0%

0 predictions

This resolution calls attention to Charcot-Marie-Tooth disease (CMT), a group of inherited nerve disorders affecting approximately 1 in 2,500 Americans, and urges increased funding for neurological research at the National Institutes of Health. CMT causes progressive muscle weakness and loss of sensation, particularly in the feet, legs, hands, and arms, and currently has no cure. The resolution seeks to elevate awareness of this under-recognized disease and strengthen the federal commitment to finding treatments.

Bill Number: 1079
Introduced: 2/25/2026
Status: Referred to the House Committee on Energy and Commerce.

Data from Congress.gov

AI-generated summary

Fact Sheet

Title: Recognizing the significance of Charcot-Marie-Tooth disease and the need for robust funding of the National Institute of Neurological Disorders and Stroke at the National Institutes of Health.
Bill Number: 1079
Sponsor: No sponsor
Status: Referred to the House Committee on Energy and Commerce.
Introduced: 2/25/2026
Summary: This resolution calls attention to Charcot-Marie-Tooth disease (CMT), a group of inherited nerve disorders affecting approximately 1 in 2,500 Americans, and urges increased funding for neurological research at the National Institutes of Health. CMT causes progressive muscle weakness and loss of sens

Data from Congress.gov

AI Summary

Plain-English explanation of this bill

This resolution calls attention to Charcot-Marie-Tooth disease (CMT), a group of inherited nerve disorders affecting approximately 1 in 2,500 Americans, and urges increased funding for neurological research at the National Institutes of Health. CMT causes progressive muscle weakness and loss of sensation, particularly in the feet, legs, hands, and arms, and currently has no cure. The resolution seeks to elevate awareness of this under-recognized disease and strengthen the federal commitment to finding treatments.

Last updated: 2/26/2026

Key Points

Main provisions of the bill

Recognizes Charcot-Marie-Tooth disease as a significant health concern affecting roughly 150,000 Americans, making it one of the most common inherited neurological disorders
Calls for robust funding of the National Institute of Neurological Disorders and Stroke (NINDS) to support research into CMT and other neurological conditions
Highlights the need for greater awareness of a disease that many people live with for decades without proper diagnosis or treatment options
As a resolution rather than legislation, it expresses Congressional support but does not allocate specific funding or create new programs

How This Impacts Americans

Potential effects on citizens and communities

This resolution would primarily benefit the estimated 150,000 Americans living with CMT and their families by raising the profile of this often-overlooked disease in Congress. While it doesn't directly provide funding, it signals Congressional support that could influence future budget decisions for neurological research and potentially accelerate the development of treatments. Increased research funding could also benefit millions more Americans affected by other neurological disorders studied by NINDS.

Policy Areas

No policy areas assigned yet.

Scope & Jurisdiction

Jurisdiction Level

federal

Congressional Session

119th Congress

Citation Reference

1079, 119th Congress (2026). "Recognizing the significance of Charcot-Marie-Tooth disease and the need for robust funding of the National Institute of Neurological Disorders and Stroke at the National Institutes of Health.". Source: Voter's Right Platform. https://votersright.org/bills/119-hres-1079

Public Opinions

Community submissions related to this bill.

Share your opinion

No public opinions yet. Be the first to submit one for this bill.